[go: up one dir, main page]

NO20065061L - Benzoxazine for the treatment of respiratory diseases - Google Patents

Benzoxazine for the treatment of respiratory diseases

Info

Publication number
NO20065061L
NO20065061L NO20065061A NO20065061A NO20065061L NO 20065061 L NO20065061 L NO 20065061L NO 20065061 A NO20065061 A NO 20065061A NO 20065061 A NO20065061 A NO 20065061A NO 20065061 L NO20065061 L NO 20065061L
Authority
NO
Norway
Prior art keywords
treatment
benzoxazine
respiratory diseases
rog
medicament
Prior art date
Application number
NO20065061A
Other languages
Norwegian (no)
Inventor
Kurt Schromm
Christoph Hoenke
Andreas Schnapp
Klaus Rudolf
Ingo Konetzki
Sabine Pestel
Frank Buettner
Hermann Schollenberger
Claudia Heine
Philipp Lustenberger
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065061L publication Critical patent/NO20065061L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Foreliggende oppfinnelse omhandler anvendelsen av forbindelsene med generell formel 1 hvori restene R, Rog Rkan ha betydningene anført i kravene og i beskrivelsen, for fremstillingen av et legemiddel for behandlingen av luftveislidelser.\\ ? H 1 Me Me Rf*j T. nA^O OH. ° (1)The present invention relates to the use of the compounds of general formula 1 in which the residues R, Rog R may have the meanings given in the claims and in the description, for the preparation of a medicament for the treatment of respiratory disorders. H 1 Me Me Rf * j T. nA ^ O OH. ° (1)

NO20065061A 2004-04-22 2006-11-02 Benzoxazine for the treatment of respiratory diseases NO20065061L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (en) 2004-04-22 2004-04-22 New drugs for the treatment of respiratory diseases
PCT/EP2005/004075 WO2005102350A1 (en) 2004-04-22 2005-04-18 Benzoxazine for treating respiratory tract diseases

Publications (1)

Publication Number Publication Date
NO20065061L true NO20065061L (en) 2006-11-07

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065061A NO20065061L (en) 2004-04-22 2006-11-02 Benzoxazine for the treatment of respiratory diseases

Country Status (20)

Country Link
EP (1) EP1765355B1 (en)
JP (1) JP2007533684A (en)
KR (2) KR20130042662A (en)
CN (1) CN1946406A (en)
AU (1) AU2005235420C1 (en)
BR (1) BRPI0510084A (en)
CA (1) CA2559700C (en)
DE (1) DE102004019539A1 (en)
DK (1) DK1765355T3 (en)
EA (1) EA012045B1 (en)
EC (1) ECSP066948A (en)
ES (1) ES2403184T3 (en)
IL (1) IL177663A (en)
NO (1) NO20065061L (en)
NZ (1) NZ551272A (en)
PL (1) PL1765355T3 (en)
SG (1) SG152233A1 (en)
UA (1) UA85707C2 (en)
WO (1) WO2005102350A1 (en)
ZA (1) ZA200606547B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for the inhalation of beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
CN101208316B (en) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 Method for preparing beta-mimetics
CA2627726A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
JP5584138B2 (en) 2008-01-11 2014-09-03 ノバルティス アーゲー Pyrimidines as kinase inhibitors
UY33597A (en) 2010-09-09 2012-04-30 Irm Llc COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
JP5959541B2 (en) 2011-02-25 2016-08-02 ノバルティス アーゲー Pyrazolo [1,5-A] pyridine as a TRK inhibitor
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
JP2019536812A (en) 2016-12-12 2019-12-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nintedanib for use in methods of treating interstitial lung disease by co-administration with olodaterol
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (en) 2023-01-20 2025-09-02 阿托基公司 Beta2-adrenergic receptor agonists for the treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (en) 2024-05-17 2025-11-20 Atrogi Ab USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
NZ522677A (en) * 2000-04-27 2004-10-29 Boehringer Ingelheim Pharma Novel, slow-acting betamimetics, a method for their production and their use as medicaments
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration

Also Published As

Publication number Publication date
AU2005235420B2 (en) 2010-10-28
KR20130042662A (en) 2013-04-26
ECSP066948A (en) 2006-12-20
KR101338947B1 (en) 2013-12-10
PL1765355T3 (en) 2013-08-30
AU2005235420A1 (en) 2005-11-03
CA2559700A1 (en) 2005-11-03
ZA200606547B (en) 2008-04-30
CA2559700C (en) 2013-06-11
EP1765355B1 (en) 2013-03-06
WO2005102350A1 (en) 2005-11-03
IL177663A (en) 2014-04-30
AU2005235420C1 (en) 2011-02-24
EA200601837A1 (en) 2007-04-27
BRPI0510084A (en) 2007-10-16
EP1765355A1 (en) 2007-03-28
SG152233A1 (en) 2009-05-29
UA85707C2 (en) 2009-02-25
JP2007533684A (en) 2007-11-22
KR20070054599A (en) 2007-05-29
DE102004019539A1 (en) 2005-11-10
ES2403184T3 (en) 2013-05-16
DK1765355T3 (en) 2013-04-08
IL177663A0 (en) 2006-12-31
NZ551272A (en) 2010-10-29
EA012045B1 (en) 2009-08-28
CN1946406A (en) 2007-04-11

Similar Documents

Publication Publication Date Title
NO20065061L (en) Benzoxazine for the treatment of respiratory diseases
ATE369353T1 (en) MEDICALLY USABLE ARYLETHANOLAMINE COMPOUNDS
NO20082496L (en) pyrazine derivatives
DE60318193D1 (en) Phenethanolaminderivate
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
GB0112348D0 (en) Compounds
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
NO20056192L (en) Capase inhibitors and their use
NO20062983L (en) Sulfonamide derivatives for the treatment of diseases
PL1696905T3 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
PL2081910T3 (en) Novel compounds
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
NO20073170L (en) Caspase inhibitors and their use
NO20064078L (en) Substituted azetidine compositions, their preparation and use as drugs
DK1641454T3 (en) Pyrazolo [3,4-B] pyridin-6-ones as GSK-3 inhibitors
DE602004008959D1 (en) BENZOÄBÜÄ1,4ÜDIOXEPINDERIVATE
NO20073176L (en) New drugs for the treatment of respiratory diseases
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
MX2011011618A (en) Therapeutic agents 713.
EA200602016A1 (en) POWDER COMPOSITIONS FOR INHALATION CONTAINING ENANTIOMERNA CLEAN AGENTISTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application